Explore 3 Stock Ideas & Industry Insights Download Free Report

BlackRock Health Sciences Trust II

Company price
16.625 USD -0.28 ( 1.69%)
Last update at 2026-11-17T20:56:00Z
VOLUME
169494
Market Cap
900.65M
P/E
5.67

Momentum Score

…

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
16.58
Low
17.12
High
52 Week Price Range
12.49
Low
15.44
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

BlackRock Health Sciences Trust II (NYSE: BMEZ) is a closed-end fund that invests primarily in equities of healthcare and life sciences companies worldwide. Long-term growth drivers include aging populations and ongoing biomedical innovation, and investors may find the fund attractive for concentrated sector exposure, active management and potential distributions.

Principal risks include sector concentration, binary R&D and regulatory outcomes that can produce volatility, and closed-end features such as shares trading at discounts to NAV and potential leverage that may amplify losses.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
16.91
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.00
ROE
-
Net Debt
-0.07M
ROCE
0.79%
Diluted EPS TTM
2.54

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 23.45M 20.02M -26.47M 59.12M 1485.00M
Net income 23.45M 20.02M -26.47M 59.12M 1485.00M
Selling general administrative 0.36M 0.30M 0.36M 6.35M 1.50M
Gross profit 24.07M 28.87M -25.97M 6.40M -
Ebit 24.43M 22.03M -26.70M 59.17M -
Ebitda 23.50M 20.02M -26.47M 59.12M 1485.00M
Depreciation and amortization -0.93M -2.01M 0.23M -0.05M -
Operating income 0.93M 8.46M 1.54M 0.05M -
Other operating expenses 0.62M 6.19M 25.97M 0.54M -
Interest expense 0.00M 0.00M - - 0.00M
Income tax expense - - - 0.01M -
Total revenue 24.07M 8.19M -25.97M 59.66M 1486.87M
Total operating expenses 0.62M 0.39M -25.97M 6.35M 1.87M
Cost of revenue 0.00M -8.46M - - -
Total other income expense net 22.53M 11.55M -28.01M - -
Net income from continuing ops - - - - 1485.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 774.59M 596.10M - - 3087.75M
Other current assets -1.20M -1.62M - - -
Total liab 6.03M 7.97M - - 64.01M
Total stockholder equity 768.57M 588.14M - - 3023.74M
Other current liab -0.28M -0.06M - - -1.76M
Common stock 942.10M 417.62M - - 1506.84M
Retained earnings -173.53M 170.52M - - 1516.90M
Other assets -25.29M 1.74M - - 19.40M
Cash 0.07M 0.00M - - 0.03M
Total current liabilities - - - - 1.76M
Net debt -0.07M -0.00M - - -0.03M
Short term debt 0.28M 0.06M - - -
Short long term debt total 0.28M 0.06M - - -
Total current assets 26.56M -0.04M - - 0.41M
Long term investments - - - - 3067.94M
Short term investments 26.49M - - - -
Net receivables 1.20M 1.58M - - 0.38M
Accounts payable - - - - 1.76M
Common stock total equity - - - - 1506.84M
Non currrent assets other -773.33M - - - -3067.94M
Non current assets total 773.33M 594.40M - - 3067.94M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total cashflows from investing activities - - - -0.04M -
Total cash from financing activities -65.52M -32.02M 0.88M 21.34M -96.98M
Net income 23.45M 20.02M -26.47M 59.12M 1485.00M
Change in cash 0.01M -0.00M 0.00M -0.21M 10.18M
Begin period cash flow 0.00M 0.00M 0.00M 0.21M 9.25M
End period cash flow 0.01M 0.00M 0.00M 0.00M 19.44M
Total cash from operating activities 65.52M 32.02M -0.87M -21.56M 107.17M
Other cashflows from investing activities - - - -0.04M -
Dividends paid 35.92M 35.10M 32.73M 29.00M -96.98M
Change to account receivables 0.22M -0.02M -0.15M 0.01M -
Sale purchase of stock -29.53M - - - -
Other cashflows from financing activities - -0.00M -0.02M 0.02M -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.51M -0.77M 0.33M 0.25M -66.76M
Other non cash items 41.56M 12.77M 25.27M -80.92M -1311.08M
Free cash flow 65.52M 32.02M -0.87M -21.56M 107.17M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
BMEZ
BlackRock Health Sciences Trust II
-0.28
1.69%
16.62 5.67 - 8.95 0.85 8.95
BLK
BlackRock Inc
-16.96
1.42%
1181.01 26.25 19.57 6.33 2.90 6.35
BX
Blackstone Group Inc
-0.58
0.50%
116.43 33.20 20.12 11.05 11.56 9.14
IVSBF
Investor AB ser. B
-1.13
2.60%
42.27 4.67 3.83 3.78 1.13 4.15
KKR
KKR & Co. Inc.
-
-%
94.50 32.68 13.66 3.58 3.22 0.68

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…